ITI Announces New Progress Milestones in Its Development Program for Acute Repetitive Seizure in Epilepsy

SADDLE BROOK, N.J.--(BUSINESS WIRE)--ITI, a privately held specialty pharmaceutical company, today announced that the company has achieved several important developments in its epilepsy product program, including